Recommendation of the Swiss Expert Committee for Biosafety on the
classification of activities using prion genes and prion protein
January 2013
--------------------------------------------------------------------------------
Page 2
2/7
Content
Introduction
................................................................................................................................
3
Legal
bases................................................................................................................................
3
Safety measures for work using TSE
agents..............................................................................
3
Risk assessment for work with prion proteins and prion
genes................................................... 4
Classification of work with TSE
agents.......................................................................................
4
References.................................................................................................................................
7
--------------------------------------------------------------------------------
Page 3
3/7
Introduction
Prions (proteinaceous infectious particles) cause neurodegenerative
diseases such as Creutzfeldt-Jakob Disease (CJD) and Kuru in humans, and Bovine
spongiform encephalopathy(BSE) and scrapie in animals. The umbrella term for
these diseases is transmissible spongiform encephalopathy (TSE), which is used
in this Recommendation. A prion originates in a PrP gene.The transcription and
translation of this gene generates the physiologically apathogenic PrPprotein
(PrPc; c = cellular). The essential, or possibly the only, component of a prion
is apathologically misfolded form of the PrP protein, PrPsc (sc =
scrapie-associated). PrPsc in turn leads to a further refolding of PrPc to
PrPsc, producing an autocatalytic chain reaction. Thus PrPsc collects in the
affected tissues, primarily in the brain, sometimes leading to irreversible
lethal pathological changes. Prions can be transmitted orally, iatrogenically or
via wounds. Thus persons who handle prions are at risk of becoming infected,
with a TSE as a consequence.
Legal bases
• Agents causing TSE are classified under group 3** (FOEN Classification of
Organisms. Module 2: Viruses; December 2011).
• The term group 3** is used for organisms that possess a limited risk of
infection to workers because air-borne transmission, according to current
scientific knowledge, cannot normally occur. Transmission can only take place
through contact with infected tissue, body fluids or contaminated medical
instruments.
• It is now certain that humans can become infected through the oral uptake
of a BSE pathogen. Thus, work must be carried out in laboratories of level 3**,
although the omission of particular safety measures may be requested (see below)
• No link to human TSEs has yet been shown for other animal TSEs (scrapie,
chronic wasting disease (CWD)). The safety measures of a level 2 laboratory are
therefore sufficient.
Safety measures for work using TSE agents
• The laboratory must satisfy the safety measurements of level 3; the
omission of particular safety measures may however be requested (see below).
• An airlock with washing and disinfection facilities must be available,
but a shower is not necessary.
• All studies in which aerosols may be produced must be performed in a
class II microbiological safety cabinet.
• An autoclave must be able to reach temperatures of 134°C (validated). It
must also be available in the same laboratory if possible, or at least in the
same building.
• Wastes and waste water must be decontaminated.
• A list of the laboratory personnel who have been in contact with prions
must be kept for at least the period prescribed in the Contain O and the PEMO.
--------------------------------------------------------------------------------
Page 4
4/7
Measures that could be omitted when working with prions, since the danger
to the environment is relatively small:
• Filtration of air exiting the laboratory with a HEPA filter
• Negative air pressure in the laboratory
• Ability to seal the area for gassing, since prions cannot be destroyed by
gas (e.g.formaldehyde). Risk assessment for work with prion proteins and prion
genes The following findings from scientific research must be borne in mind when
the risks associated with handling prions are being assessed. Studies with
native and with mutant recombinant prion proteins are also included in the
considerations.
• Experimental studies on scrapie in mouse and in hamster have been carried
out for several decades. There are no indications that the scrapie agent
represents an increased risk either for occupationally exposed persons or for
the public and the environment. To date, it has not been demonstrated that
scrapie can be transmitted to humans. However, rodents infected with scrapie
agents should be handled using the same safety precautions as rodents infected
with natural, mouse-specific pathogens (classified into group 2).
• It has been shown that the primary structure of the prion protein plays
an important role in transmission of prions from one species to another
(Prusiner et al., 1990; Colby et al.,2011). The sequence of the bovine PrP gene
shows greater homology to the sequence of the human gene than the sequence of
the mouse or hamster gene (Gabriel et al., 1992).Although it is possible to
transmit bovine TSE agents to humans, it appears unlikely that mouse- or
hamster-specific TSE agents can be transmitted to humans.
• It is now possible to transform native recombinant PrPc or PrPc from
tissue extracts into infectious prions (PrPsc). Particularly when using PMCA
technology (Protein Misfolding Cyclic Amplification), infectious prions
reproduce efficiently in the laboratory (Castilla et al.,2005; Wang et al.,
2010). It is vital that this be taken into account in the risk assessment.
• Certain activities using PrP genes should be treated with caution.
Bearing in mind the current gaps in knowledge, the following activities present
an increased risk to humans and the environment: (1) cloning of PrP genes in
host organisms that could replicate in/on humans, and (2) the cloning and
expression of modified PrP genes in prokaryotic and eukaryotic expression
systems where there is a possibility of producing infectious PrPSc.
• Mutations in the DNA sequence of the PrP gene, without a host organism,
poses a negligible risk according to the current state of science. This activity
may thus be classified under Class 1. Classification of work with TSE agents
Based on the risk assessment above, the following recommendations can be made
for work with prions and prion proteins (see also Table on p. 5):
Animals
• Autopsy of sick cattle should be done in accordance with the Epizootic
Diseases Ordinance and according to special clinical regulations, in principle
using the safety measures of level 2(see Diagram on p. 6). Infected cattle used
for research purposes can be kept in safety level 1, since transmission via
aerosol can be virtually ruled out.
--------------------------------------------------------------------------------
Page 5
5/7
• Activities with animals infected with rodent-adapted scrapie prions, i.e.
animal husbandry and care, invasive procedures (e.g. inoculation with prions),
and post-mortem examinations and tissue sampling from animals, are classified as
class 2.
• Activities with live mice and hamsters infected with BSE prions,
BSE-related prions or human TSE agents (e.g. animal husbandry and care), are
classified as class 2. The risk of bite and scratch wounds is reduced by
handling the animals with long, blunt forceps.Invasive procedures (e.g.
inoculation with TSE agents) as well as post-mortem examinations of infected
animals and tissue sampling are classified under class 3.
Tissue
All experimental studies involving lymphoid and neural animal tissue that
contains rodent-adapted scrapie prions are classified as class 2. Activities
using tissue from humans and animals that contains human or bovine TSE agents
are classified as class 3.
Classification of work using genetically modified PrP genes and proteins
Origin of the PrP genes
sheep, rodent cattle, human
Cloning of DNA in plasmid with inactive promoter 1 1
State of the protein
PrPc PrPSc PrPc PrPSc
Expression in prokaryotic and eukaryotic expression systems that replicate
in/on humans 1 2 1 2
Expression in hosts that replicate in/on humans 1 2 2 3
--------------------------------------------------------------------------------
Page 6
6/7
Overview of the classification of pathological work using prions
--------------------------------------------------------------------------------
Page 7
7/7
References
• Advisory Committee on Dangerous Pathogens, Spongiform Encephalopathy
Advisory Committee. Transmissible spongiform encephalopathy agents: safe working
and the prevention of infection. London (1990). HSE Books, PO Box 1999, Sudbury,
Suffolk CO106FS.
• Prusiner SB, Scott M, Foster D, Pan KM, Groth D, Mirenda C, Torchia M,
Yang SL, SerbanD, Carlson GA, et al. Transgenetic studies implicate interactions
between homologous PrP isoforms in scrapie prion replication. Cell 63, 673-86
(1990).
• Colby DW and Prusiner B. De novo generation of prions. Nature 9, 771-777
(2011).
• Gabriel JM, Oesch B, Kretzschmar H, Scott M, Prusiner SB. Molecular
cloning of a candidate chicken prion protein. Proc Natl Acad Sci U S A 89,
9097-101 (1992).
• Council Directive of 26 November 1990 on the protection of workers from
risks related to exposure to biological agents at work of 26 November 1990
(90/679/EEC). Official Journal of the European Communities No. L 374/1 of
31.12.1990, and modifications up to and including 6.12.1997 (97/65/EC).
• Risk assessment of laboratories involving the manipulation of
unconventional agents causing TSE. (2009) isp/wiv.
• Guidance from the ACDP TSE Risk Management Subgroup http://www.dh.gov.uk/ab/ACDP/TSEguidance/index.htm
• Castilla et al. In vitro generation of infectious scrapie prions (2005)
Cell 121, 195-206
• Deleault et al. Formation of native prions from minimal components in
vitro (2007) PNAS104, 9741-9746
• Wang et al. Generating a prion with bacterially expressed recombinant
prion protein (2010)Science, 327, 1132-1135
Classification of activities using prion genes and ... - EFBS - admin.ch
TSE Transmissible spongiforme encephalopathic agents
Biological agents associated with transferable spongiform encephalopathies
are classified as 3**.
Work with these agents must be done according to safety level 3, though
certain level 3 measures can be omitted (see Classification of work using prion
genes and prion proteins, www.efbs.ch ).
Classification of Organisms. Part 2- Viruses. Status January 2013
Sunday, October 27, 2013
A Kiss of a Prion: New Implications for Oral Transmissibility
From: Terry S. Singeltary Sr.
Sent: Monday, October 28, 2013 11:48 AM
Subject:
Re: [CJDVoice] A Kiss of a Prion: New Implications for Oral
Transmissibility
hi xxxxx,
no, I can’t really put your mind to rest xxxxx. wish I could. I believe the
kiss of the prion was done several years ago. the deaths of cjd to man and wife,
man and cat, friend friend and friend, ....as with what Brown et al stated with
the man and his wife i.e. ‘ therefore, we are left with the unanswerable
alternatives of human-to-human transmission or the chance occurrence of sporadic
CJD in a husband and wife.’ it is what it is, however, I would not loose any
sleep over it. we are (in my opinion), exposed to the TSE prion in so many
different ways in every day life. the potential for exposure and then becoming
infected via taking care of a loved one with TSE prion disease, in my opinion
risk factor there from is minimal, if proper precautions are taken, and even if
they were not, the chance of becoming infected from a kiss, or casual contact is
low, but I do not think it is zero, actually, far from it. I put this all
together for a documentation of the known facts to date, of the potential casual
human to human transmission. I did not put it together to scare anyone. with
aerosol transmission of the TSE prion a reality now, infectivity in urine and
feces and transmission there from being reality now with the TSE prion disease,
I don’t see how anyone can rule _out_ the potential for transmission of the TSE
prion via a kiss (a vehicle for transmission of the TSE prion via saliva), or
even for a cut or open wound (all a cut is and transmission there from, is an
crude inoculation of sorts, and inoculation has been proven to be an efficient
mode of transmission for the TSE prion disease), even the eye, from either one
of the body fluids now that how proven to be infections. I can’t see why we have
such safety protocols for laboratory workers working with the TSE prion disease,
but yet the same officials will say it’s o.k. for the public, friends, and or
family members to do just the opposite with their loved ones when succumbing to
the CJD TSE prion disease. don’t get me wrong, I did it too, and would probably
do it again as far as kissing my mom. but science is science, and the
transmission studies speak for themselves with the bodily fluids. simply put,
which is all I was saying, we can’t say never, and or that none of these cases
to date, have not been, and or will not be, a potential vehicle for
transmission. I believe, and this is my opinion, that more concern for casual
transmission with body fluids and materials there from, should be put forth to
families with their loved ones, and I think that the safety protocols there from
should be revised, to match that of the laboratory settings. again, this is my
opinion. your opinion, and or others here, may read the same science and feel
different out the findings. ...take care, kind regards, terry
SUBSTANCE DATA SHEET
HUMAN PRION AGENTS
FOR USE IN RESEARCH LABORATORIES
SECTION I - INFECTIOUS AGENT
Name: Creutzfeldt-Jakob agent, Kuru agent
Synonym or Cross Reference:: Subacute spongiform encephalopathy,
Creutzfeldt-Jakob disease (CJD), Kuru, Transmissible Spongiform Encephalopathy
(TSE).
Characteristics: Filterable, self-replicating agent, slow infectious
pathogen, prion protein (PrP)
SECTION II - RECOMMENDED PRECAUTIONS
Containment Requirements: Biosafety level 3 facilities, practices and
containment equipment for activities involving these agents; also listed under
biosafety level 2 with special precautions; level of containment will depend on
the nature of the manipulations and the amount of sera, bio/necropsy materials
handled
Protective Clothing: Gown and gloves when handling potentially infectious
materials; eye protection may also be indicated
Other Precautions: Extreme care must be taken to avoid accidental
autoinoculation or other parenteral inoculations of infectious tissues and
fluids
SECTION III - HANDLING INFORMATION
Spills: Allow any potential aerosols to settle; wearing protective
clothing, gently cover spill with paper towel and apply 1N sodium hydroxide,
starting at perimeter and working towards the center; allow sufficient contact
time (1 hour) before clean up
Disposal: Decontaminate before disposal; steam sterilization (132·C for 1
hour), disinfection with 1N sodium hydroxide for 1 hour, incineration
Storage: In sealed containers that are appropriately labeled
The main precaution to be taken by laboratorians working with
prion-infected or contaminated material is to avoid accidental puncture of the
skin.3 Persons handling contaminated specimens should wear cut-resistant gloves
if possible. If accidental contamination of unbroken skin occurs, the area
should be washed with detergent and abundant quantities of warm water (avoid
scrubbing); brief exposure (1 minute to 1N NaOH or a 1:10 dilution of bleach)
can be considered for maximum safety.6 Additional guidance related to
occupational injury are provided in the WHO infection control guidelines.6
Unfixed samples of brain, spinal cord, and other tissues containing human prions
should be processed with extreme care in a BSL-2 facility utilizing BSL-3
practices.
Bovine Spongiform Encephalopathy Although the eventual total number of
variant CJD cases resulting from BSE transmission to humans is unknown, a review
of the epidemiological data from the United Kingdom indicates that BSE
transmission to humans is not efficient.9 The most prudent approach is to study
BSE prions at a minimum in a BSL-2 facility utilizing BSL-3 practices. When
performing necropsies on large animals where there is an opportunity that the
worker may be accidentally splashed or have contact with high-risk materials
(e.g., spinal column, brain) personnel should wear full body coverage personal
protective equipment (e.g., gloves, rear closing gown and face shield).
Disposable plasticware, which can be discarded as a dry regulated medical waste,
is highly recommended. Because the paraformaldehyde vaporization procedure does
not diminish prion titers, BSCs must be decontaminated with 1N NaOH and rinsed
with water. HEPA filters should be bagged out and incinerated. Although there is
no evidence to suggest that aerosol transmission occurs in the natural disease,
it is prudent to avoid the generation of aerosols or droplets during the
manipulation of tissues or fluids and during the necropsy of experimental
animals. It is further strongly recommended that impervious gloves be worn for
activities that provide the opportunity for skin contact with infectious tissues
and fluids.
The main precaution to be taken when working with prion-infected or
contaminated material is to avoid puncture of the skin. If accidental
contamination of skin occurs, the area is swabbed with In sodium hydroxide
(NaOH) for 5 minutes and then washed with copious amounts of water. Unfixed
samples of brain, spinal cord, and other tissues containing human prions should
be processed with extreme care at BSL 3.
Prions are characterized by extreme resistance to conventional inactivation
procedures including irradiation, boiling, dry heat, and chemicals (formalin,
betapropiolactone, alcohols). Sterilization of rodent brain extracts with high
titers of prions requires autoclaving at 132C for 4.5 hours. Denaturing organic
solvents such as phenol or chaotropic reagents such as guanidine isothiocyanate
or alkali such as NaOH can also be used for sterilization. Disposable
plasticware, which can be discarded as a dry waste, is highly recommended.
Although there is no evidence to suggest that aerosol transmission occurs
in the natural disease, it is prudent to avoid the generation of aerosols or
droplets during the manipulation of tissues or fluids and during the necropsy of
experimental animals. Formaldehyde-fixed and paraffin-embedded tissues,
especially of the brain, remain infectious. Some investigators recommend that
formalin-fixed tissues from suspected cases of prion disease be immersed for 30
min in 96% formic acid or phenol before histopathologic processing, but such
treatment may severely distort the microscopic neuropathology.
another interesting aspect of the TSE prion disease is KURU ;
Figure 25. All cooking. including that of human flesh from diseased
kinsmen. was done in pits with steam made by pouring water over the hot stones,
or cooked in bamboo cylinders in the hot ashes. Children participated in both
the butchery and the handling of cooked meat, rubbing their soiled hands in
their armpits or hair, and elsewhere on their bodies. They rarely or never
washed. Infection with the kuru virus was most probably through the cuts and
abrasions of the skin. or from nose-picking, rye (eye...tss) rubbing, or mucosal
injury.
These detailed descriptions will be published elsewhere but have reaffirmed
the oral histories of endocannibalism in the Fore recorded previously12,22–24
and that this practice ceased abruptly at the time of Australian administrative
control over the kuru areas. Although isolated events might have occurred for a
few years after this prohibition, we are confident that new exposures of
individuals to kuru at mortuary feasts would not have occurred after 1960. Not
only have no cases of kuru been recorded in people born after 1959 (and only
nine were recorded in those born after 1956); but also all the 11 last recorded
cases of kuru that we report here were born before 1950. If any source of
infection remained, whether from surreptitious cannibalism, possible ground
contam-ination with human prions at sites where food was prepared, or other
lateral routes, we would expect individuals born after this period to have
kuru—especially since children are thought to have had shorter incubation
periods than adults. However, no such cases have been observed. Additionally,
although a fraction of hamster-adapted scrapie prions have been shown to survive
in soil for at least 3 years,25 the mortuary feast practices (during which the
entire body would be consumed) were undertaken so that any substantial
contamination of soil would not have occurred, and traditional bamboo knives and
leaf plates were burned after the feast. Furthermore, no clusters of kuru cases,
as seen earlier in the epidemic,26 have been recorded for many years.... http://kuru-tse.blogspot.com/2008/08/conference-celebrating-end-of-kuru-50.html
Kuru: The Science and the Sorcery
Special Jury Prize Winner, Pacific International Documentary Film Festival
2011.
This is the true story of one of the most incredible and challenging
medical detective stories of the 20th Century; a history of human tragedy,
adventure and discovery. It is the story of the Fore, a Papuan community
immersed in cannibalistic mortuary practices and sorcery in one of the most
remote regions on the planet, and the tragic disease that threatened to wipe out
their entire population.
In 1961, a young Australian medical researcher, Michael Alpers, puts up his
hand to work on a new and strange disease in the Eastern Highlands of Papua New
Guinea. There, he teams up with an American outer, Dr Carleton Gajdusek, who has
been in the local Fore region since 1957. For Michael it is the beginning of a
lifelong obsession.
Together, they are amidst a major epidemic. It is killing over 200 people a
year with devastating effects. It mainly targets women and children. The local
people, the Fore, call the disease kuru, their word for shivering. They believe
it is caused by sorcery.
Michael and Carleton are baffled by the disease. There are no scientific
disciplines to guide them as they attempt to unravel its mysteries. By pure
chance, a link is made to a strange transmissible animal disease in sheep,
Scrapie. The two kuru researchers embark on a 10-year experiment to see if the
fatal degenerative brain disease in humans could be transmissible like
Scrapie.
The decision is made to perform an autopsy on a kuru victim and inoculate
the kuru material into a chimpanzee. Kigea, ayoung girl in the village is
identified as being in the early stages of kuru. Kigea’s family, gives Michael
permission to perform an autopsy upon her death.
A brain sample taken from Kigea after her death is flown to the USA and
injected into a chimpanzee called Daisy. While Michael follows the progress of
the transmission experiment, he starts to collate all the recorded data on kuru
and begins to suspect cannibalism as the cause of the spreadof the
disease.
Within two years, he diagnoses Daisy with kuru. This is a defining moment.
It confirms kuru is transmissible and can cross the species barrier. The
revelation, together with epidemiological data collated with anthropologist
Shirley Lindenbaum, links the Fore’s mortuary feasts (consumption of dead
relatives) to the transmission of kuru. Cannibalism is the cause, and its origin
is linked to a rare disease called Creutzfeldt Jakob Disease(CJD), but the story
of kuru is far from over.
The infecting agent is the first new pathogen – prions – to be discovered
in over 100 years. Research results in two Nobel prizes: it’s discoveries
turning scientific understanding upside down, causing rifts in the beliefs ofthe
science community.
Then Mad Cow Disease (Bovine Spongiform Encephalopathy or BSE) reared its
head in the mid 1980s, and 10 years later the human variant CJD. All eyes turned
to kuru, the only model of a prion epidemic in human populations. Many unknowns
still surround prion diseases: there is no cure for kuru, or any of the prion
diseases. The effects are devastating and unprecedented incubation periods can
extend beyond 50 years.
Michael is the key and heart to this story, providing unique access to the
Fore people, and the world’s other leading authorities on the matter; including
Americans Prof. DC Gajdusek (Nobel Prize 1976), Prof. Stan Prusiner (Nobel Prize
1997), Prof Shirley Lindenbaum (Anthropologist) and British Prof. John Collinge
(Director, MRC Prion Unit, UK).
Kuru: The Science and the Sorcery combines history, science and
anthropology to tell a unique and ongoing ‘history of science’ documentary
spanning five decades. It intertwines the thinking of great minds, locally and
internationally, to reveal how this rare disease in the remote highlands of PNG
exploded to international attention and how Prion research has now revealed we
are all descendants of a remote past of cannibal practices.
Kuru: The Science and the Sorcery Australian scientist Michael Alpers
dedicated over 50 years to researching Kuru, an obscure and incurable brain
disease unique to the Fore people of New Guinea. Kuru was once thought to be a
psychosomatic illness, an infection, a genetic disorder, even a sorcerer's
curse, but Alpers' findings pointed to cannibalism as the culprit. Yet a recent
discovery has proven to be even more disturbing: the malady is linked to mad cow
disease and its human equivalent, variant CJD. With a decades-long incubation
period, could a larger outbreak be on its way?
human flesh taste very sweet
KURU EPIDEMIOLOGICAL PATROLS
Michael Alpers
First Reports
People of the Kuru region part 1
boy playing with animal bladder, blowing it up like a balloon. ...
People of the Kuru region part 2
Monday, November 19, 2012
Prion in Saliva of Bovine Spongiform Encephalopathy–Infected Cattle
kind regards, terry
============end...tss==============
*** Saturday, November 2, 2013 ***
Exploring the risks of a putative transmission of BSE to new species
Wednesday, September 25, 2013
Presence of subclinical infection in gene-targeted human prion protein
transgenic mice exposed to atypical BSE
Wednesday, October 30, 2013
SPECIFIED RISK MATERIAL (SRM) CONTROL VERIFICATION TASK FSIS NOTICE 70-13
10/30/13
Monday, August 26, 2013
The Presence of Disease-Associated Prion Protein in Skeletal Muscle of
Cattle Infected with Classical Bovine Spongiform Encephalopathy
Tuesday, September 24, 2013
NORDION (US), INC., AND BIOAXONE BIOSCIENCES, INC., Settles $90M Mad Cow
TSE prion Contamination Suit Cethrin(R)
*** Case 0:12-cv-60739-RNS Document 1 Entered on FLSD Docket 04/26/2012
Page 1 of 15 ***
Tuesday, July 2, 2013
APHIS USDA Administrator Message to Stakeholders: Agency Vision and Goals
Eliminating ALL remaining BSE barriers to export market
Saturday, November 2, 2013
APHIS Finalizes Bovine Import Regulations in Line with International Animal
Health Standards while enhancing the spread of BSE TSE prion mad cow type
disease around the Globe
*** The discovery of previously unrecognized prion diseases in both humans
and animals (i.e., Nor98 in small ruminants) demonstrates that the range of
prion diseases might be wider than expected and raises crucial questions about
the epidemiology and strain properties of these new forms. We are investigating
this latter issue by molecular and biological comparison of VPSPr, GSS and
Nor98.
Saturday, July 6, 2013
*** Small Ruminant Nor98 Prions Share Biochemical Features with Human
Gerstmann-Sträussler-Scheinker Disease and Variably Protease-Sensitive
Prionopathy
Research Article
Wednesday, October 09, 2013
WHY THE UKBSEnvCJD ONLY THEORY IS SO POPULAR IN IT'S FALLACY, £41,078,281
in compensation REVISED
Thursday, October 10, 2013
CJD REPORT 1994 increased risk for consumption of veal and venison and lamb
Monday, October 14, 2013
Researchers estimate one in 2,000 people in the UK carry variant CJD
proteins
Friday, August 16, 2013
*** Creutzfeldt-Jakob disease (CJD) biannual update August 2013 U.K. and
Contaminated blood products induce a highly atypical prion disease devoid of
PrPres in primates
WHAT about the sporadic CJD TSE proteins ?
WE now know that some cases of sporadic CJD are linked to atypical BSE and
atypical Scrapie, so why are not MORE concerned about the sporadic CJD, and all
it’s sub-types $$$
Sunday, August 11, 2013
Creutzfeldt-Jakob Disease CJD cases rising North America updated report
August 2013
*** Creutzfeldt-Jakob Disease CJD cases rising North America with Canada
seeing an extreme increase of 48% between 2008 and 2010
Sunday, October 13, 2013
CJD TSE Prion Disease Cases in Texas by Year, 2003-2012
Sunday, September 08, 2013
Iatrogenic Creutzfeldt-Jakob disease via surgical instruments and
decontamination possibilities for the TSE prion
Thursday, September 26, 2013
Minimise transmission risk of CJD and vCJD in healthcare settings Guidance
Sunday, June 9, 2013
TSEAC March 14, 2013: Transmissible Spongiform Encephalopathies Advisory
Committee Meeting Webcast
Tuesday, May 28, 2013
Late-in-life surgery associated with Creutzfeldt-Jakob disease: a
methodological outline for evidence-based guidance
*** U.S.A. 50 STATE BSE MAD COW CONFERENCE CALL Jan. 9, 2001 ***
Tuesday, March 05, 2013
A closer look at prion strains Characterization and important implications
Prion
7:2, 99–108; March/April 2013; © 2013 Landes Bioscience
TSS
